The economic impact of factor VIII inhibitors in patients with haemophilia
- 6 January 2004
- journal article
- website
- Published by Wiley in Haemophilia
- Vol. 10 (1), 63-68
- https://doi.org/10.1046/j.1365-2516.2003.00849.x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Economic modelling of different treatment strategies for haemophilia A with high‐responding inhibitorsHaemophilia, 2003
- Economic Impact of Treating Inhibitor PatientsPathophysiology of Haemostasis and Thrombosis, 2002
- Defining the Impact of Hemophilia: The Academic Achievement in Children With Hemophilia StudyPublished by American Academy of Pediatrics (AAP) ,2001
- Inhibitor treatment: State of the artSeminars in Hematology, 2001
- Immune tolerance induction in hemophilia patients with inhibitors: costly can be cheaperBlood, 2000
- The impact of inhibitors on the cost of clotting factor replacement therapy in haemophilia A in CanadaHaemophilia, 1999
- Prophylactic Use of Factor VIII: an Economic EvaluationThrombosis and Haemostasis, 1998
- Incidence of development of factor VIII and factor IX inhibitors in haemophiliacsThe Lancet, 1992